Clinical trials
Terminated Observational Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precision Therapeutics | 3 |
| Vanderbilt-Ingram Cancer Center | 2 |
| British Columbia Cancer Agency | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Chang Gung Memorial Hospital | 1 |
| Columbia University | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| Lyell Immunopharma, Inc. | 1 |
| Mustang Bio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 21 |
| Breast Neoplasms | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Hodgkin Disease | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Neoplasm Metastasis | 4 |
| Ovarian Neoplasms | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.